IDV vehicle

W81K0222D0018

REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP, BASE + 4 OPTION YEARS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeDEFENSE HEALTH AGENCY HCD WEST
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6515 — Medical and Surgical Instruments, Equipment, and Supplies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$1.1M
Start dateOct 1, 2022
Current end dateNot available
Potential end dateNot available
Latest award activityMay 6, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 6, 2026P00010$0BIOCHEMICAL ANTIBIOTIC SUSCEPTIBILITY TESTING
Apr 7, 2026P00009$0BIOCHEMICAL ANTIBIOTIC SUSCEPTIBILITY TESTING
Aug 15, 2025P00008$0BIOCHEMICAL ANTIBIOTIC SUSCEPTIBILITY TESTING
May 1, 2025P00007$0BIOCHEMICAL ANTIBIOTIC SUSCEPTIBILITY TESTING
May 8, 2024P00006$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP MOD P00005 EXERCISE OPTION 2 10/01/2024-09/30/2025
Apr 4, 2024P00005$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP MOD P00005 INCREASE MAX QTY FOR CLINS 1004, 2004, 3004, 4004
Aug 8, 2023P00004$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP MOD P00004 EXERCISE OPTION I 10/01/2023-09/30/2024
Jun 30, 2023P00003$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP MOD P00003: INCORPORATE FAR 52.204-27
Apr 28, 2023P00002$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP: MOD P00002 CLIN RESTRUCTURING
Feb 14, 2023P00001$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP MOD P00001 TO CHANGE DODAAC TO HT0908
Sep 13, 20220$0REAGENTS FOR BIOCHEM ANTIBIOTICS SUSCEP, BASE + 4 OPTION YEARS

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.